Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News Annual Scientific Meeting Awards Research Read More Feb 28 2022 | Cytokinetics announces start of SEQUOIA-HCM, a phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy Industry News Industry Read More Feb 28 2022 | Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation, the Heart Failure Society of America and the American Association of Heart Failure Nurses to Help Increase Awareness of Genetic Heart Disorders Industry News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 67 Page 68 Page 69 Page 70 Current page 71 Page 72 Page 73 Page 74 Page 75 … Next page Next › Last page Last »
Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More
Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More
Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News Annual Scientific Meeting Awards Research Read More
Feb 28 2022 | Cytokinetics announces start of SEQUOIA-HCM, a phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy Industry News Industry Read More
Feb 28 2022 | Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation, the Heart Failure Society of America and the American Association of Heart Failure Nurses to Help Increase Awareness of Genetic Heart Disorders Industry News Industry Read More
